23.08.2011 Copyright® Raisio A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol.

Slides:



Advertisements
Similar presentations
Copyright® Raisio Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and.
Advertisements

Walter Lab: Gut microbiome and its interactions with metabolic disease
The Research Question Alka M. Kanaya, MD Associate Professor of Medicine, Epidemiology & Biostatistics UCSF October 3, 2011.
The concept of Diabetes & CV risk: A lifetime risk challenge Vascular function as an early sign of trouble: How can the inhibition of cholesterol absorption.
Copyright® Raisio A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: Results.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
BHS Guidelines for the management of hypertension BHS IV, 2004 and Update of the NICE Hypertension Guideline, 2006 Guidelines for management of hypertension:
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
Simvastatin Increases HDL-C and Apolipoprotein A-1 Levels Significantly More Than Atorvastatin John P. Kastelein, Evan A. Stein, Michael A. Davidson, John.
Effects of Low-Fat Dairy Consumption on Markers of Low- Grade Systemic Inflammation and Endothelial Function in Overweight and Obese Subjects: An Intervention.
The Science of Plant Stanol Ester. Contents Background Plant stanol ester and LDL-cholesterol lowering Dose-response of plant stanol ester with high daily.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Lipid-Modulating Effects of Evacetrapib, a Novel CETP Inhibitor, Administered as Monotherapy or in Combination with the Most Commonly-Used Statins SJ.
Hyperlipidemia John Baer.
Copyright® Raisio Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic.
Department of Family & Community Medicine
Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.
High-density lipoprotein and very-low-density lipoprotein have opposing roles in regulating tumor-initiating cells and sensitivity to radiation in inflammatory.
Downloaded from Slide 1 Dual Inhibition of Two Sources of Cholesterol: Absorption and Production in Patients with Type 2 Diabetes.
Fenofibrate Intervention and Event Lowering in Diabetes FIELDFIELD Presented at The American Heart Association Scientific Sessions, November 2005 Presented.
Copyright® Raisio The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat-soluble vitamins Gylling et.
© Copyright 2009 by the American Association for Clinical Chemistry Nonfasting Lipids, Lipoproteins, and Apolipoproteins in Individuals With and Without.
Copyright® Raisio Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment.
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 2 ARBITER-2 Trial Presented at The American Heart Association Scientific.
Copyright® Raisio Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population Miettinen TA et.
European Union Garlic Inflammation Study (EUGIS) in Humans Martijn van Doorn Sonia Espirito Santo TNO-PH Leiden The Netherlands CHDR Leiden The Netherlands.
Collaborative Atorvastatin Diabetes Study CARDS Dr Sachin Kadoo.
Clinical Trial Results. org Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity.
Copyright® Raisio Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced.
Study Flow Diagram Holvoet P, et al. JAMA 2008;299: The Figure shows the selection of 1889 participants who did not have metabolic syndrome at year.
Copyright® Raisio Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and.
Presentation Title R3 이지영 / 김 수 중교 수 님. Introduction Lowering LDL cholesterol levels with statins : Reduce the risk of cardiovascular disease Vascular.
Plant stanol and sterol esters - mechanism and safety issues -
Cholesterol-lowering effects of a stanol- ester containing low-fat margarine used in conjunction with a strict lipid-lowering diet Andersson A et al. Eur.
Plant stanol esters in human studies Professor Helena Gylling University of Kuopio.
Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease Department of Nephrology R3. Yeehyung Kim.
1 A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia Diabetes Care 28:1547–1554,
HEARTS & MINDS Lowering Cholesterol with Plant Stanol Ester Opening Remarks Herbert Schuster, M.D., Ph.D. Humboldt University Berlin, Berlin, Germany.
Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial Michael Miller MD,
Cholesterol-Lowering Ability of a Phytostanol Softgel Supplement in Adults with Mild to Moderate Hypercholesterolemia Woodgate D et al. Lipids. 2006;41:
GLYPICAN-4 LEVELS IN RELATION WITH HORMONAL AND METABOLIC PROFILE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME Doç.Dr.Özlem ALTINKAYA.
Plant stanol esters in low-fat yogurt reduces total and low-density lipoprotein cholesterol and low-density lipoprotein oxidation in normocholesterolemic.
Arabinda Mohan Bhattarai, MBBS, MD (Biochemistry) Asst Prof, NAIHS
Westerweel PE et al. Eur Heart J 2008;29:
Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride.
Copyright © 2011 American Medical Association. All rights reserved.
Senior Medical Director, Cardiovascular
Copyright © 2012 American Medical Association. All rights reserved.
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
National Cholesterol Education Program
AIM-HIGH Niacin Plus Statin to Prevent Vascular Events
Oxford Niacin Trial.
FATS- Familial Atherosclerosis Treatment Study
The ASSERT Study.
Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:
Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY.
Baseline characteristics of HPS participants by prior diabetes
Type 2 diabetes: Overlap of clinical conditions
Residual Risk After Statin Therapy:
Section 7: Aggressive vs moderate approach to lipid lowering
SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.
FOURIER Trial design: Patients with established cardiovascular disease on statin therapy were randomized to evolocumab 140 mg subcutaneous every 2 weeks.
New Lipid-Lowering Guidelines
Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]
Addressing Cardiovascular Events:
(A) Low-density lipoprotein-cholesterol (LDL-C) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. (A) Low-density.
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
Change in markers of glycometabolism and cardiovascular risk profile.
Presentation transcript:

Copyright® Raisio A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients Plat et al. J Nutr 2009

Plat et al Background I Patients with metabolic syndrome are at an increased risk of cardiovascular disease. Several factors contribute to the risk apart from the ”traditional” high LDL-cholesterol, including high TG, low HDL and proinflammatory profile, all present in metabolic syndrome. Meta-analysis by Naumann et al suggested that plant stanol ester may also lower elevated serum TG concentration.

Plat et al Background II The aim of the study was to evaluate if plant stanol ester can improve the lipid-profile in metabolic syndrome patients. Effects of plant stanol ester were studied alone and in combination with low-dose Simvastatin.

Plat et al Methods I 36 metabolic syndrome patients  3-week run-in with placebo yogurt drink and placebo tablet  randomized into 4 treatment groups for 8 weeks placebo group (n=9); placebo yogurt drink + placebo tablet plant stanol ester group (n=9); yogurt drink with 2 g/d plant stanols + placebo tablet statin group (n=10); placebo yogurt drink + 10 mg simvastatin combination group (n=8); yogurt drink with 2 g/d plant stanols + 10 mg simvastatin

Plat et al Methods II Fasting blood samples week 2 & 3 (run-in) week 10 & 11 (experimental period) Analyses for lipids and lipoproteins markers of inflammation and endothelial function clinical safety variables

Plat et al Results I Participants had a clear atherogenetic phenotype that did not differ among the groups Compliance to the study protocol was excellent No changes in dietary parameters, weight or inflammation markers

Plat et al Results II In metabolic syndrome patients, plant stanol ester, Simvastatin or the combination lowered non-HDL- cholesterol concentration by 12.8 %, 30.7 % and 35.4 % respectively, compared to placebo TGs were lowered by 27.5 %, 21.7 % and 32.7 %, respectively, compared to placebo

Plat et al CHANGES IN CHOLESTEROL AND TG CONCENTRATIONS Control Plant stanol ester % Total cholesterol Simvastatin Plant stanol ester + simvastatin Non-HDL Cholesterol TG a a a a b b b b b c cc c Effects of plant stanol ester, Simvastatin, or the combination on serum cholesterol and triglyceride concentrations Values between each group carrying a different letter are significantly different (p<0.05)

Plat et al Conclusions In addition to lowering serum non-HDL-cholesterol concentration, consumption of plant stanol ester lowered serum TG concentrations by 27 % in metabolic syndrome patients.

10 Thank You!